Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition.

about

Anti-cancer Activity of Natural and Synthetic Capsaicin Analogs.Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy

P2860

Q47778782-D8ECF20F-6822-4E0A-8FBA-92C170C57CA4 Q58800891-78161152-9C1A-440C-BE74-6CF119926C21

P2860

Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition.

Item

http://www.wikidata.org/entity/Q38804415

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evodiamine induces apoptosis a ...... 6K1-mediated Mcl-1 inhibition.

@en

type

Item

label

Evodiamine induces apoptosis a ...... 6K1-mediated Mcl-1 inhibition.

@en

prefLabel

Evodiamine induces apoptosis a ...... 6K1-mediated Mcl-1 inhibition.

@en

P1476

Evodiamine induces apoptosis a ...... 6K1-mediated Mcl-1 inhibition.

@en

P2093

Chong Zhang

http://www.w3.org/2001/XMLSchema#string

Da-Yong Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-Ping Pan

http://www.w3.org/2001/XMLSchema#string

Jiao Sun

http://www.w3.org/2001/XMLSchema#string

Jing-Yin Dong

http://www.w3.org/2001/XMLSchema#string

Neng-Ming Lin

http://www.w3.org/2001/XMLSchema#string

Shi-Ying Mao

http://www.w3.org/2001/XMLSchema#string

Wen-Jue Wu

http://www.w3.org/2001/XMLSchema#string

Yang-Ling Li

http://www.w3.org/2001/XMLSchema#string

Yi-Ming Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

Role of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patients

Update of research on drug resistance in small cell lung cancer chemotherapy

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism

Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Erlotinib in previously treated non-small-cell lung cancer

PI3K pathway alterations in cancer: variations on a theme

Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancer

P2888

s12032-015-0726-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-015-0726-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039610803

http://www.w3.org/2001/XMLSchema#string

P698

26757927

http://www.w3.org/2001/XMLSchema#string

Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition.

about

P2860

P2860

Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698